Chemoinformaics analysis of 19 –hydroxy-labda 8(17),13-diene-15,16-olide
| Molecular Weight | 302.458 | nRot | 3 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 17 |
| Exact Molecular Weight | 302.225 | nRing | 3 |
| Solubility: LogS | -5.582 | nHRing | 1 |
| Solubility: LogP | 5.659 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.0078 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.725 |
| Synth | 4.193 |
| Natural Product Likeliness | 2.588 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.096 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.815 |
| MDCK | 0.0000151 |
| BBB | 0.286 |
| PPB | 0.975421 |
| VDSS | 1.946 |
| FU | 0.0161524 |
| CYP1A2-inh | 0.164 |
| CYP1A2-sub | 0.52 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.555 |
| CYP2c9-inh | 0.346 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.144 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.176 |
| CYP3a4-sub | 0.203 |
| CL | 10.276 |
| T12 | 0.121 |
| hERG | 0.012 |
| Ames | 0.008 |
| ROA | 0.538 |
| SkinSen | 0.061 |
| Carcinogencity | 0.05 |
| EI | 0.612 |
| Respiratory | 0.943 |
| NR-Aromatase | 0.026 |
| Antiviral | No |
| Prediction | 0.524448 |